What is NDC 51407-503?

51407-503 is the product NDC for Abiraterone Acetate, Abiraterone acetate 125 mg/1 tablet, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Abiraterone Acetate?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Abiraterone Acetate NDC 51407-503 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-503Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0503Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-503-12	5140705031251407050312	120 TABLET in 1 BOTTLE, PLASTIC (51407-503-12)Marketed from Sep 4, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abiraterone Acetate
Generic name (nonproprietary): abiraterone acetate
Active ingredients: Abiraterone acetate — 125 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Golden State Medical Supply, Inc.NDC labeler code 51407
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 210308
Marketing start: May 22, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 17A1 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)
Identifiers: Product ID 51407-503_5467687f-51ac-1f50-e063-6394a90ab3f7SPL ID 5467687f-51ac-1f50-e063-6394a90ab3f7SPL set ID 445e70a1-25bd-8fc1-e063-6394a90a1a43RxCUI 2046579UNII EM5OCB9YJ6
Pharmacologic class: Cytochrome P450 17A1 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407050312 followed by a unit qualifier and the quantity

Package 51407-0503-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2026.

Indications (excerpt from the label)

Abiraterone Acetate is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer. Abiraterone Acetate is a CYP17 inhibitor indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51407-503

What is NDC 51407-503?: 51407-503 is the product NDC for Abiraterone Acetate, Abiraterone acetate 125 mg/1 tablet, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Abiraterone Acetate.
What is the active ingredient?: Abiraterone acetate.
Who is the labeler?: Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abiraterone Acetate?: 28 other product NDCs are listed under this name. See all Abiraterone Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abiraterone Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	AvPAK	50268-032	50268-0032-12
Abiraterone Acetate	Abiraterone acetate 250 mg/1	TabletOral	Dr. Reddys Laboratories Inc	75907-224	75907-0224-04
Abiraterone Acetateabiraterone	Abiraterone acetate 250 mg/1	TabletOral	American Health Packaging	60687-790	60687-0790-21
Abiraterone Acetate	Abiraterone acetate 500 mg/1	TabletOral	Dr. Reddys Laboratories Inc	43598-468	43598-0468-3843598-0468-60
Abiraterone Acetateabiraterone	Abiraterone acetate 250 mg/1	TabletOral	Amneal Pharmaceuticals LLC	60219-1165	60219-1165-07
Abiraterone Acetateabiraterone	Abiraterone acetate 500 mg/1	TabletOral	Amneal Pharmaceuticals LLC	60219-1754	60219-1754-06
Abiraterone acetate	Abiraterone acetate 500 mg/1	Tablet, Film coatedOral	Florida Pharmaceutical Products, LLC	71921-177	71921-0177-06
abiraterone acetate	Abiraterone acetate 250 mg/1	TabletOral	Florida Pharmaceutical Products, LLC.	71921-178	71921-0178-20
abiraterone acetate	Abiraterone acetate 500 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-882	68462-0882-60
abiraterone acetate	Abiraterone acetate 500 mg/1	TabletOral	NORTHSTAR RX LLC	72603-111	72603-0111-01

All 29 Abiraterone Acetate NDCs

Other NDCs under NDA 210308

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 210308
Product	Strength	Form · route	Labeler	Product NDC
Yonsaabiraterone acetate	Abiraterone acetate 125 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	47335-401